Education

Ph.D. in Molecular Medicine, Faculty of Medicine, Université Laval, CHU de Québec, 2013

Publications

1. Theriault, P., Bordeleau, M. and Rivest, S. (2016). Isolation and purification of murine microglial cells for flow cytometry. Bio-protocol 6(1): e1703.
   
2. ElAli, A., Bordeleau, M., Thériault, P., Filali, M., Lampron, A. and Rivest, S. (2015). Tissue-Plasminogen Activator Attenuates Alzheimer's Disease-Related Pathology Development in APPswe/PS1 Mice. Neuropsychopharmacology.
   
3. Thériault, P., ElAli, A. and Rivest, S. (2015). The dynamics of monocytes and microglia in Alzheimer's disease. Alzheimers Res Ther 7(1): 41.
   
4. ElAli, A., Thériault, P. and Rivest, S. (2014). The role of pericytes in neurovascular unit remodeling in brain disorders. Int J Mol Sci 15(4): 6453-6474.
   
5. ElAli, A., Thériault, P., Préfontaine, P. and Rivest, S. (2013). Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation. Acta Neuropathol Commun 1: 75.
   *Article flagged on BioMed Central as Highly Accessed
   
6. Michaud, J. P., Hallé, M., Lampron, A., Thériault, P., Prefontaine, P., Filali, M., Tribout-Jover, P., Lanteigne, A. M., Jodoin, R., Cluff, C., Brichard, V., Palmantier, R., Pilorget, A., Larocque, D. and Rivest, S. (2013). Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology. Proc Natl Acad Sci U S A 110(5): 1941-1946.
   *Research Highlight, Nature Reviews Neurology 9, 120
   
7. Filali, M., Lalonde, R., Thériault, P., Julien, C., Calon, F. and Planel, E. (2012). Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD). Behav Brain Res 234(2): 334-342.